Deirdre Coombe, PhD, BSc Hons (University of Adelaide, Australia) is a Professor at Curtin University, Western Australia. She is recognised internationally for her work with the extracellular matrix and carbohydrate-protein interactions and the therapeutic potential of carbohydrate-based drugs. In recent years, her work on the extracellular matrix has focused on its contribution to cell and tissue differentiation, as well as to cancer biology and cancer cell migration and invasion. She has worked at the Australian National University in Canberra, as well as in the UK at Imperial Cancer Research Fund, London; National Institute for Medical Research, London, and the Glycobiology Institute and Sir William Dunn School of Pathology, both of Oxford University. In 1994 she established her research lab at the Institute for Child Health Research in Perth, Western Australia, before joining Curtin University in 2000. She has had continuous research funding for 30 years and has published extensively with over 60% of publications in Q1 journals and she is senior/first author on almost 80% of her publications. She has edited an eBook, and is an associate editor for Frontiers in Immunology. She is an inventor on 13 granted patents. She co-founded the start-up company Glycan Biosciences Pty Ltd/Glycosynnovations Pty Ltd. Her experience straddles academia and business and she has a keen interest in the translation of academic, biomedical research into the clinic.
Deirdre Coombe, PhD, BSc Hons (University of Adelaide, Australia) is a Professor at Curtin University, Western Australia. She is recognised internationally for her work with the extracellular matrix and carbohydrate-protein interactions and the therapeutic potential of carbohydrate-based drugs. In recent years, her work on the extracellular matrix has focused on its contribution to cell and tissue differentiation, as well as to cancer biology and cancer cell migration and invasion. She has worked at the Australian National University in Canberra, as well as in the UK at Imperial Cancer Research Fund, London; National Institute for Medical Research, London, and the Glycobiology Institute and Sir William Dunn School of Pathology, both of Oxford University. In 1994 she established her research lab at the Institute for Child Health Research in Perth, Western Australia, before joining Curtin University in 2000. She has had continuous research funding for 30 years and has published extensively with over 60% of publications in Q1 journals and she is senior/first author on almost 80% of her publications. She has edited an eBook, and is an associate editor for Frontiers in Immunology. She is an inventor on 13 granted patents. She co-founded the start-up company Glycan Biosciences Pty Ltd/Glycosynnovations Pty Ltd. Her experience straddles academia and business and she has a keen interest in the translation of academic, biomedical research into the clinic.